DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives $32.67 Consensus PT from Analysts

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) has been assigned an average recommendation of “Moderate Buy” from the eleven brokerages that are currently covering the company, Marketbeat Ratings reports. Four investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average 1 year price target among brokers that have updated their coverage on the stock in the last year is $32.67.

Several equities analysts recently commented on the company. Robert W. Baird cut their target price on DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating for the company in a research report on Monday, July 22nd. StockNews.com raised DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a report on Monday. Evercore ISI dropped their price target on DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating for the company in a report on Tuesday, October 8th. Barrington Research reaffirmed an “outperform” rating and set a $36.00 price target on shares of DENTSPLY SIRONA in a report on Friday, September 20th. Finally, Stifel Nicolaus dropped their price target on DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating for the company in a report on Thursday, July 18th.

Institutional Investors Weigh In On DENTSPLY SIRONA

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. UMB Bank n.a. increased its holdings in DENTSPLY SIRONA by 430.3% in the third quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier’s stock valued at $25,000 after purchasing an additional 753 shares during the last quarter. LRI Investments LLC increased its holdings in DENTSPLY SIRONA by 82.7% in the second quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock valued at $31,000 after purchasing an additional 564 shares during the last quarter. Rothschild Investment LLC bought a new stake in DENTSPLY SIRONA in the second quarter valued at about $32,000. Van ECK Associates Corp acquired a new position in DENTSPLY SIRONA in the third quarter valued at about $42,000. Finally, Central Pacific Bank Trust Division acquired a new position in DENTSPLY SIRONA in the first quarter valued at about $64,000. Institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Price Performance

DENTSPLY SIRONA stock opened at $23.23 on Friday. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.33 and a quick ratio of 0.87. The company has a market capitalization of $4.71 billion, a PE ratio of -27.34, a price-to-earnings-growth ratio of 1.12 and a beta of 1.00. DENTSPLY SIRONA has a one year low of $22.85 and a one year high of $37.60. The business has a 50 day simple moving average of $25.18 and a 200 day simple moving average of $26.37.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its earnings results on Wednesday, July 31st. The medical instruments supplier reported $0.49 EPS for the quarter, missing the consensus estimate of $0.50 by ($0.01). The company had revenue of $984.00 million for the quarter, compared to the consensus estimate of $993.61 million. DENTSPLY SIRONA had a positive return on equity of 11.86% and a negative net margin of 4.75%. DENTSPLY SIRONA’s quarterly revenue was down 4.3% compared to the same quarter last year. During the same quarter last year, the business earned $0.51 EPS. On average, sell-side analysts forecast that DENTSPLY SIRONA will post 1.98 EPS for the current fiscal year.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.